title: Immune reconstitution hepatitis E:  a neglected complication of antiretroviral therapy in Africa?
authors.forename: Monique I
authors.initials: MI
authors.lastname: Andersson
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Preiser
authors.forename: Tongai G
authors.initials: TG
authors.lastname: Maponga
authors.forename: Izak
authors.initials: I
authors.lastname: Heys
authors.forename: Jantjie J
authors.initials: JJ
authors.lastname: Taljaard
authors.forename: Christo
authors.initials: C
authors.lastname: van Rensburg
authors.forename: Richard S
authors.initials: RS
authors.lastname: Tedder
authors.forename: Samreen
authors.initials: S
authors.lastname: Ijaz
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005838:Genotype; D016751:Hepatitis E / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D008297:Male; D012367:RNA, Viral / Q000187:drug effects; D013019:South Africa; D000637:Transaminases / Q000187:drug effects; D019562:Viral Load / Q000187:drug effects
chemical_list: D019380:Anti-HIV Agents; D012367:RNA, Viral; D000637:Transaminases